UK Lines Up COVID-19 Vaccine Supply Deals With Novavax, J&J

The UK government is set to purchase 90 million COVID-19 vaccine doses from Novavax and Johnson & Johnson.

Under the agreements, the government will purchase 60 million doses of Novavax’s NVX-CoV2373 and 30 million doses of J&J’s Ad26.COV2.S. The deal with J&J includes an option to purchase an additional 22 million doses.

The UK government will also support a phase 3 trial of Novavax’s NVX-CoV2373 in the UK and a separate, long-term global phase 3 trial of J&J’s Ad26.COV2.S.